Epic Sciences expands partnership with LabCorp to provide circulating tumor cell analysis
Epic Sciences announced an agreement with LabCorp® to provide circulating tumor cell technology and support oncology clinical trials in Asia through Covance Drug Development. Covance will send samples to Epic's clinical lab for downstream detection and molecular characterization of CTCs. July 07, 2015